biottt001
Biologicalexperimental
Clinical trial activity
6 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jan 22, 2024 (NCT06215846)
Timeline
Indications
Mechanism of action
- Oncolytic virusSupplementation
Oncolytic virus supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07264569 | Phase 1/Phase 2 (Phase 2) | Jun 25, 2025 | Henan Medical University |
| NCT07150767 | Phase 1 | Mar 26, 2025 | Government of China |
| NCT06763965 | Phase 1/Phase 2 (Phase 2) | Nov 26, 2024 | Government of China |
| NCT06283121 | Phase 2 | Apr 2, 2024 | China Medical University, Government of China |
| NCT06283134 | Phase 1 | Apr 2, 2024 | China Medical University, Government of China |
| NCT06215846 | Phase 1 | Jan 22, 2024 | China Medical University, Government of China |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 5 | 3 | 2 | 2024 |
| China Medical University | Academic/Hospital | 3 | 2 | 2 | 2024 |
| Henan Medical University | Academic/Hospital | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1